Archive · 26 Aug 2026
HaystackAnalytics Expands Genomic Centers for Infectious Disease Diagnostics
HaystackAnalytics wants to make it easier for doctors to find out which infections patients have.
Some infection tests take a long time because samples must be sent to faraway specialized laboratories.
The company uses genomics, which studies genetic information, to help diagnose complicated infections.
It works with more than 40 Genomic Centers of Excellence in India.
These centers get sequencing machines, software, and other support from the company.
This allows hospitals and laboratories to perform some tests closer to patients.
HaystackAnalytics plans to increase the number of centers to 100 within the next year.
The company says this could make advanced infection diagnosis more accessible and affordable.
HaystackAnalytics says infectious disease diagnosis is hindered by fragmented care, complex illnesses, and difficult testing processes.
The company uses a network of more than 40 Genomic Centers of Excellence across India.
Partner centers receive sequencing technology, software, and operational support to conduct genomic tests in-house.
HaystackAnalytics plans to expand its network to 100 centers in India over the next 12 months.
The company says distributed genomics could bring advanced infection testing closer to hospitals, doctors, and patients.
- Who
- HaystackAnalytics, its partner Genomic Centers of Excellence, hospitals, laboratories, doctors, and patients.
- What
- The company is expanding distributed genomics for infectious disease diagnostics.
- When
- HaystackAnalytics plans to expand its network over the next 12 months.
- Where
- India.
- Why
- To make genomic infection testing more accessible and bring diagnosis closer to patients and treatment facilities.
- Current network
- More than 40 Genomic Centers of Excellence in India
- Planned network
- Up to 100 centers within the next 12 months
- Technology
- Genomic sequencing, software, and operational support
- Testing model
- Partner hospitals and laboratories conduct genomic tests in-house
- Main challenge
- Limited point-of-care capacity, lengthy centralized testing, and complicated diagnostic procedures
- Company goal
- Make advanced genomics accessible, applicable, and affordable for hospitals, laboratories, and patients